News

Medscape4d
Novel Gene Risk Score Predicts Outcomes After RYGB Surgery
A new gene risk score, informed by machine learning, can predict weight-loss outcomes after Roux-en-Y gastric bypass surgery.
The Lancet13d
Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial
aDepartment of Surgery, University of Minnesota, Minneapolis, MN, USA bDepartment of Medicine, Division of Endocrinology and Diabetes, University of Minnesota, Minneapolis, MN, USA cDivision of ...
Too Old to Operate15d
Unmasking Hidden Dangers: Managing Common & Rare Complications After Gastric Bypass Surgery
In one case report presented at AACE 2025, Sacoto et al. present a 63-year-old woman with a history of Roux-en-Y gastric bypass (RYGB) who experienced recurrent symptomatic hypoglycemia—both fasting ...
SciELO17d
Evaluation of l-cell activity in the small intestine according to the extension of the biliopancreatic loop in patients undergoing Roux-en-Y gastric by-pass
Background Individuals with severe obesity and type 2 diabetes mellitus have reduced secretion of incretins by L cells. Studies suggest an increase in L cell activity according to the length of the ...
Frontiers19d
Esophageal Suspension Method for Hand-Sewn Esophagojejunostomy After Totally Laparoscopic Total Gastrectomy: A Simple, Safe, and Feasible Suturing Technique
1. Kitano S, Iso Y, Moriyama M, Sugimachi K. Laparoscopy-assisted Billroth I gastrectomy. Surg laparosc Endosc. (1994) 4:146–8.
New York Post29d
New daily ‘gastric bypass pill’ leads to consistent weight loss — and no side effects: study
The makers of the experimental drug SYNT-101 claim it mimics the effects of gastric bypass surgery while preserving lean muscle mass better than GLP-1 drugs. SYNT-101 is a once-daily pill designed ...